CannabisNewsBreaks

WednesdayJan 09, 2019 2:17 pm

CannabisNewsBreaks – Therma Bright, Inc. (TSX.V: THRM) (OTC: THRBF) Combining its Thermal Therapy Technology with CBD to Target Chronic Pain

Medical device technology provider Therma Bright (TSX.V: THRM) (OTC: THRBF) is developing an innovative pain relief therapy that utilizes its thermal therapy technology in combination with medical grade cannabis or cannabidiol (“CBD”) from hemp in the form of a cream or gel. A recent article discussing the company reads, “In October, Therma Bright revealed that it is also developing testing for a hemp cannabidiol (CBD)-based pain relief therapy that will use creams, gels or salves in concert with its thermal-generation products to target various forms of general or chronic pain such as back pain, arthritic pain and other orthopedic concerns.…

Continue Reading

WednesdayJan 09, 2019 10:57 am

CannabisNewsBreaks – The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF) (FRA: 53S1) Gains Conditional Approval for Listing on the Toronto Stock Exchange

The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF) (FRA: 53S1) this morning announced that it has received conditional approval from the Toronto Stock Exchange to graduate from the TSX Venture Exchange and list its common shares on the TSX. Final approval of the listing is subject to Supreme Cannabis meeting certain customary conditions required by the TSX, and the company intends to issue an additional statement when the TSX confirms the date on which trading on the TSX will commence. “Graduating to the TSX will broaden our investment appeal and leave us well positioned to execute on our strategic…

Continue Reading

WednesdayJan 09, 2019 9:20 am

CannabisNewsBreaks – The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF) Inks Medical Cannabis Supply Agreement with Shoppers Drug Mart

The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF), through its subsidiary The Flowr Group (Okanagan) Inc. (collectively “Flowr” or the company), this morning announced its entrance into an agreement with Shoppers Drug Mart, a division of Loblaw Companies Limited (TSX: L), to supply medical cannabis on a purchase order basis. Flowr will supply the leading drug store retailer with its FlowrRx brand of premium medical cannabis products. Initially, the products will be sold online only as Canadian regulations presently restrict the sale of medical cannabis in retail pharmacies, making Shoppers’ new ecommerce site the exclusive direct-to-patient online provider of FlowRx products.…

Continue Reading

TuesdayJan 08, 2019 2:36 pm

CannabisNewsBreaks – Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) Proprietary Technology Transforms the Way Molecules Enter the Body

Biotechnology company Lexaria Bioscience’s (CSE: LXX) (OTCQX: LXRP) revolutionary technology, DehydraTECH, alters the way that fat soluble, plant-derived molecules are absorbed into the body. A recent article further discussing the company reads, “Chemicals or intimidating complex ingredients that require disclosure on food labels are not required additions when using DehydraTECH. Instead the edible tech works with commons GRAS ingredients that can be organic and gluten- and dairy-free. It does all of this while still costing partners less than a penny per serving to implement, making DehydraTECH a win-win for the partner and consumer, who both gain from the improved performance…

Continue Reading

TuesdayJan 08, 2019 1:56 pm

CannabisNewsBreaks – Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) Focuses on Medical Cannabis, Hemp and CBD-related Companies as Export Laws Begin to Shift in Israel

Redfund Capital (CSE: LOAN) (Frankfurt: O3X4) (OTC: PNNRF), a merchant bank that provides debt and equity funding to mid- and late-stage companies, is currently focusing on medical cannabis, hemp and cannabidiol (“CBD”) related companies. A recent article discussing the company reads, “Recent developments in regulation and research and development in the cannabis space are set to swell the project pipeline of Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (Frankfurt: O3X4). In November, a government committee in Israel approved the first draft of a law on the export of medical cannabis, a move welcomed by the industry, with one commentator (http://cnw.fm/UmSY8)  opining,…

Continue Reading

TuesdayJan 08, 2019 10:53 am

CannabisNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTC: TGODF) Appoints Two New Directors, Adding Deep Medical and Pharmaceutical Experience to its Board

Cannabis-focused research and development company The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF) today announced appointment of Dr. Caroline MacCallum and Jacques Dessureault to its board of directors. Per the update, Dr. MacCallum is one of the world's most prominent experts in cannabinoid-based medicine. At the University of British Columbia, she is an internist, complex pain and cannabinoid clinician, researcher and clinical instructor in the Department of Medicine, an adjunct professor in the Faculty of Pharmaceutical Sciences Program and an associate member of the Department of Palliative Care. Dr. MacCallum is also Greenleaf Medical Clinic’s medical director, where she…

Continue Reading

TuesdayJan 08, 2019 10:08 am

CannabisNewsBreaks – Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) Enters Technology-Focused Cannabis Vertical via Investment in Headset, Inc.; Secures $80M Financial Development for PharmHouse

Canopy Rivers (TSX.V: RIV) (OTC: CNPOF) this morning announced its completion of an equity investment in Headset, Inc., a data and analytics service provider for the cannabis industry. Representing its first entry into a technology-focused cannabis vertical, Canopy Rivers subscribed for CAD $4,084,500 of Series A Preferred Shares in Headset. In addition, the company recently announced that its 49 percent-owned joint venture PharmHouse Inc. has entered into a syndicated credit facility with the Bank of Montreal (“BMO”), as agent and lead lender, and with Canadian Imperial Bank of Commerce and Concentra Bank as lenders. According to the update, under the…

Continue Reading

FridayJan 04, 2019 1:50 pm

CannabisNewsBreaks – The Flowr Corporation’s (TSX.V: FLWR) (OTC: FLWPF) High Production Standards Result in Premium Quality Products

The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF), a Canadian Licensed Producer, is leveraging its cannabis cultivation expertise to provide top-notch products. A recent article discussing the company reads, “Flowr’s high production standards and its facilities that are designed to pharmaceutical industry standards allow it to grow cannabis that meets Health Canada’s strict standards for cleanliness without the need for irradiation. Cannabis grown in greenhouses or lower quality facilities is almost always blasted with radioactive material (a process called irradiation) to kill mold and bacteria so that it can pass Health Canada inspection. While such treatment is allowed, it is known…

Continue Reading

FridayJan 04, 2019 12:28 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Brings Aggressive Growth Plan to Action

Biotechnology company and drug delivery platform innovator Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) recently put its aggressive growth strategy into effect with the additions of a new corporate controller, a head of its legal division and more office staff. The company also intends to increase its lab personnel in 2019. A recent article further discussing the company reads, “Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP), a drug delivery platform innovator, has announced aggressive growth plans, including the addition of key personnel, a special focus on its lab R&D activities in 2019 and the issue of new stock options. … It…

Continue Reading

FridayJan 04, 2019 9:59 am

CannabisNewsBreaks – Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) Secures Over $2.4M in Initial Cannabis Product Sales in California

Vertically integrated cannabis company Sunniva (CSE: SNN) (OTCQX: SNNVF) this morning announced that it has secured more than USD $2.4 million in future sales of Sunniva branded cannabis products, to be completed in the first four months of 2019. Achieved through one of the company’s existing retail relationships, this marks Sunniva’s first cannabis product sales in the state of California, and it anticipates securing additional sales contracts in the near future. Sunniva’s current product inventory is estimated at a value in excess of USD $5 million and consists of ultrapure cannabis distillate, premium concentrates and flower. The company intends to…

Continue Reading